The University of Chicago Header Logo

Connection

Hedy Kindler to Carcinoid Tumor

Back to Details
This is a "connection" page, showing publications Hedy Kindler has written about Carcinoid Tumor.
Hedy Kindler
Connection Strength
0.059
Carcinoid Tumor
  1. Phase II study of the proteasome inhibitor bortezomib (PS-341) in patients with metastatic neuroendocrine tumors. Clin Cancer Res. 2004 Sep 15; 10(18 Pt 1):6111-8.
    View in: PubMed
    Score: 0.059
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.